Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Recro Pharma Inc (NQ: REPH )

N/A UNCHANGED
Last Price Updated: 4:00 PM EDT, Mar 21, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open -
Bid (Size) 1.600 (2)
Ask (Size) 2.300 (3)
Prev. Close 2.090
Today's Range N/A - N/A
52wk Range N/A - N/A
Shares Outstanding 90,127,280
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Recro Pharma Earnings Perspective: Return On Capital Employed
According to data from Benzinga Pro, during Q4, Recro Pharma's (NASDAQ:REPH) reported sales totaled $22.30 million. Despite a 32.39% increase in earnings, the company posted a... 
Via Benzinga
Recap: Recro Pharma Q4 Earnings
Recro Pharma (NASDAQ:REPH) reported its Q4 earnings results on Tuesday, March 1, 2022 at 04:00 PM. Here's what investors need to know about the announcement. Earnings Recro... 
Via Benzinga

Performance

More News

Read More
Earnings Scheduled For March 1, 2022
Via Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
Via Benzinga
5 Penny Stocks Insiders Are Buying
Via Benzinga
Recro Secures Manufacturing Contract From NIH For Nasal Spray Analgesic
Via Benzinga
The Week Ahead In Biotech (Aug. 8-14): Jazz Pharma FDA Decision, Earnings Deluge and IPOs In The Spotlight
Via Benzinga
Exposures Product Safety
Earnings Scheduled For May 6, 2021
Via Benzinga
The Daily Biotech Pulse: Double Dose Of Positive Tidings For Merck, Alkermes Slips On Partial Termination Of J&J Licensing Deal, Amgen Migraine Drug Data
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For October 12, 2021
Via Benzinga
Recro Pharma's Return On Capital Employed Overview
Via Benzinga
Recro and BioCorRx Expand Development and Manufacturing Relationship to Support BICX104, an Implantable Naltrexone Pellet for the Treatment of Opioid Use Disorder
Via NewMediaWire
Exposures COVID-19 Product Safety
12 Health Care Stocks Moving In Wednesday's After-Market Session
Via Benzinga
60 Biggest Movers From Yesterday
Via Benzinga
38 Stocks Moving In Monday's Mid-Day Session
Via Benzinga
78 Biggest Movers From Friday
Via Benzinga
Recro Pharma: Q2 Earnings Insights
Via Benzinga
Earnings Scheduled For August 9, 2021
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
70 Biggest Movers From Friday
Via Benzinga
56 Stocks Moving In Friday's Mid-Day Session
Via Benzinga
Earnings Preview for Recro Pharma
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.